Association of type and intensity of physical activity with plasma biomarkers of inflammation and insulin response
Carregando...
Citações na Scopus
24
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
LEE, Dong Hoon
WU, Kana
TABUNG, Fred K.
GIOVANNUCCI, Edward L.
Citação
INTERNATIONAL JOURNAL OF CANCER, v.145, n.2, p.360-369, 2019
Resumo
Several biological mechanisms linking physical activity with cancer have been proposed. However, the influence of specific components of physical activity (volume, type and intensity), and their interaction with adiposity and diet, on cancer-related biomarkers remain unclear. We used cross-sectional data on 7,219 men in the Health Professionals Follow-up Study (1992-1994) with C-reactive protein (CRP), interleukin-6 (IL6), tumor necrosis factor alpha receptor 2 (TNF alpha R2), adiponectin, C-peptide and triglycerides/high-density lipoprotein cholesterol ratio (TG/HDL). Details on physical activity, diet and adiposity were assessed by questionnaires. We used multivariable-adjusted linear regression analyses to estimate relative concentrations of biomarkers by physical activity. Total physical activity was favorably associated with all biomarkers in a fairly linear manner. Comparing the highest (63+ metabolic equivalent (MET)-hr/week) to the lowest (0-8.9 MET-hr/week) physical activity groups, the percent relative difference in concentration of biomarkers was -31% for CRP, -22% for IL6, -8% for TNF alpha R2, +9% for adiponectin, -22% for C-peptide, and -20% for TG/HDL. These differences were modestly attenuated after adjustment for adiposity. For the same total MET-hours of physical activity, the association was stronger for men engaging in both aerobic and resistance exercises compared to those engaging in aerobic only. However, no difference was found between those engaging in vigorous activities (>= 20% of total MET-hours) compared to those who did smaller amount of vigorous activities. Physical activity showed similar associations for these biomarkers regardless of adiposity and dietary pattern. In conclusion, high physical activity, preferably aerobic plus resistance training, was associated with favorable cancer-related biomarkers.
Palavras-chave
physical activity, diet, adiposity, inflammation, insulin, interaction
Referências
- AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011
- Alessa HB, 2017, MED SCI SPORT EXER, V49, P1817, DOI 10.1249/MSS.0000000000001287
- Astrom Maj-Briit, 2010, Front Biosci (Schol Ed), V2, P96
- Bao Y, 2013, JNCI-J NATL CANCER I, V105, P95, DOI 10.1093/jnci/djs474
- Bird Stephen R, 2016, BMJ Open Sport Exerc Med, V2, pe000143, DOI 10.1136/bmjsem-2016-000143
- Brown JC, 2012, COMPR PHYSIOL, V2, P2775, DOI 10.1002/cphy.c120005
- Buffart LM, 2014, CANCER TREAT REV, V40, P327, DOI 10.1016/j.ctrv.2013.06.007
- ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014
- Chen L, 2013, CANCER CAUSE CONTROL, V24, P1837, DOI 10.1007/s10552-013-0261-6
- Cronin O, 2017, QJM-INT J MED, V110, P629, DOI 10.1093/qjmed/hcx091
- Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333
- Fedewa MV, 2017, BRIT J SPORT MED, V51, P670, DOI 10.1136/bjsports-2016-095999
- Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S
- Giovannucci E, 2017, CANCER CAUSE CONTROL, V52, P826
- Giovannucci E, 2018, JNCI-J NATL CANCER I, V110, P935, DOI 10.1093/jnci/djy091
- Gong TT, 2015, INT J CANCER, V137, P1967, DOI 10.1002/ijc.29561
- Grontved A, 2012, ARCH INTERN MED, V172, P1306, DOI 10.1001/archinternmed.2012.3138
- Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z
- Hernandez AV, 2015, EUR J CANCER, V51, P2747, DOI 10.1016/j.ejca.2015.08.031
- International Agency for Research on Cancer (IARC), 2002, IARC HDB CANC PREV, V6
- Iyengar NM, 2016, J CLIN ONCOL, V34, P4270, DOI 10.1200/JCO.2016.67.4283
- Kang DW, 2017, CANCER EPIDEM BIOMAR, V26, P355, DOI 10.1158/1055-9965.EPI-16-0602
- Keating SE, 2017, OBES REV, V18, P943, DOI 10.1111/obr.12536
- Keum N, 2016, JAMA ONCOL, V2, P1146, DOI 10.1001/jamaoncol.2016.0740
- Kitahara CM, 2014, CANCER EPIDEM BIOMAR, V23, P2840, DOI 10.1158/1055-9965.EPI-14-0699-T
- Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602
- Lee DH, 2017, BRIT J NUTR, V118, P858, DOI [10.1017/S0007114517002665, 10.1017/s0007114517002665]
- de Rezende LFM, 2018, BRIT J SPORT MED, V52, P826, DOI 10.1136/bjsports-2017-098391
- Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1602/neurorx.1.2.182
- McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325
- Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548
- O'Flanagan CH, 2017, IARC WORK GROUP REP, V10
- Olson OC, 2017, SCIENCE, V358, P1130, DOI 10.1126/science.aao5801
- Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967
- Plowman SA, 2013, EXERCISE PHYSL HLTH
- RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W
- Rosner B, 2008, AM J EPIDEMIOL, V167, P653, DOI 10.1093/aje/kwm348
- Song MY, 2013, CANCER RES, V73, DOI 10.1158/1538-7445.AM2013-103
- Tabung FK, 2016, BRIT J NUTR, V116, P1787, DOI 10.1017/S0007114516003755
- Tabung FK, 2016, J NUTR, V146, P1560, DOI 10.3945/jn.115.228718
- Verheggen RJHM, 2016, OBES REV, V17, P664, DOI 10.1111/obr.12406
- Wang J, 2015, CANCER EPIDEM BIOMAR, V24, P1199, DOI 10.1158/1055-9965.EPI-15-0187
- Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376
- Wolpin BM, 2013, JNCI-J NATL CANCER I, V105, P1027, DOI 10.1093/jnci/djt123
- World Cancer Research Fund/ American Institute for Cancer Research, CONT UPD PROJ EXP RE